Migræne kliniske forsøg i Georgia
9 studier for Migræne søger deltagere på steder i Georgia.
Byer i Georgia
Officiel studietekst (engelsk)
Study of EVO756 in Adults With Migraine
- Clinical Integrative Research Center of Atlanta, Atlanta
- Accel Research Site-Decatur-Alcanza, Decatur
RekruttererFase 2
Alder 18 til 64 · Alle køn · Opdateret 2. okt. 2026 · NCT07616128A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Coastal Heritage Clinical Research, Hinesville
RekruttererFase 1
Alder 6 til 11 · Alle køn · Opdateret 28. sep. 2026 · NCT06995729Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Clinical Trial Office, Augusta
- Augusta University, Augusta
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 28. sep. 2026 · NCT05156398Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- CenExel iResearch, LLC, Decatur
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 24. sep. 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- CenExel iResearch, LLC, Decatur
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 24. sep. 2026 · NCT04649242Responding With Evidence and Access for Childhood Headaches
- Clinical Integrative Research Center of Atlanta, Inc, Atlanta
Rekrutterer
Alder 10 til 17 · Alle køn · Opdateret 21. sep. 2026 · NCT05889624Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Rare Disease Research /ID# 231046, Atlanta
- Clinical Integrative Research Center of Atlanta (CIRCA) /ID# 231134, Atlanta
- Coastal Georgia Child Neurology /ID# 231409, Brunswick
- og 1 flere
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 14. sep. 2026 · NCT05125302A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine
- Vista Clinical Research, Newnan
Rekrutterer
Alder 22 til 84 · Alle køn · Opdateret 28. aug. 2026 · NCT07719608A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- DelRicht Research, Atlanta
- Drug Studies America, Marietta
- Sleep Care Research Institute d/b/a Clinical Research Atlanta-Stockbridge, Stockbridge
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 20. aug. 2026 · NCT07645924Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.